Cancer Research

The landscape of preventative oncology is undergoing a seismic shift as clinical data from 2026 reveals that prostate cancer screening protocols have finally closed the efficacy gap with breast cancer mammography. For decades, the medical community viewed these two diagnostic pathways through

The European Commission’s recent authorization of AstraZeneca’s Imfinzi marks a significant shift in the therapeutic landscape for patients battling resectable gastric and gastro-esophageal junction cancers across the continent. This decision formalized the use of durvalumab as a perioperative

Ivan Kairatov is a titan in the biopharmaceutical sector, renowned for his deep expertise in the evolution of antibody-drug conjugates (ADCs). With a career spanning decades of research and development, he has been at the forefront of navigating the complex intersection of biotechnology and

The staggering realization that nearly twenty million individuals receive a cancer diagnosis annually across the globe has catalyzed a shift from generalized medical protocols toward highly nuanced, patient-specific interventions. In the United States alone, the National Cancer Institute tracks

Recent clinical investigations suggest that the traditional boundary between dental hygiene and systemic wellness is rapidly dissolving as researchers identify startling connections between gum disease and digestive malignancies. While most people view a routine dental cleaning as a simple cosmetic

The current landscape of oncological care often hits a diagnostic ceiling where genomic sequencing reveals potential mutations but fails to predict which specific therapies will actually trigger a biological response in an individual patient. This gap in clinical knowledge remains a primary